Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?

Journal of Periodontal Research

Volumn 47, Issue 5, 2012, Pages 655-660

  Glimvall, P ^a   Wickstrom C ^a   Jansson, H ^a  

^a MALMÖ UNIVERSITY   (Sweden)

Author keywords

Cytokine; Periodontal risk factor; Saliva

Indexed keywords

BIOLOGICAL MARKER; LACTOFERRIN; LYSOZYME; SECRETORY IMMUNOGLOBULIN;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; CHEMISTRY; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTAL POCKET; PERIODONTICS; PERIODONTIUM; RADIOGRAPHY; SALIVA; SMOKING; TOOTH RADIOGRAPHY;

ADULT; ALVEOLAR BONE LOSS; BIOLOGICAL MARKERS; CHRONIC PERIODONTITIS; DIABETES COMPLICATIONS; FEMALE; GINGIVAL HEMORRHAGE; GINGIVITIS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; LACTOFERRIN; MALE; MIDDLE AGED; MURAMIDASE; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; RADIOGRAPHY, BITEWING; SALIVA; SMOKING;

EID: 84865554240     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2012.01479.x     Document Type: Article

References (41)

1. Tonetti MS, Claffey N; European Workshop in Periodontology group C. Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. J Clin Periodontol 2005;32:210-213.
2. Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 2008;35:89-105.
3. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997;14:216-248.
4. Armitage GC. The complete periodontal examination. Periodontol 2000 2004;34:22-33.
5. Heitz-Mayfield LJ. Disease progression: identification of high-risk groups and individuals for periodontitis. J Clin Periodontol 2005;32:196-209.
6. Lang NP, Joss A, Orsanic T, Gusberti FA, Siegrist BE. Bleeding on probing. A predictor for the progression of periodontal disease?. J Clin Periodontol 1986;13:590-596.
7. Lang NP, Tonetti MS. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health Prev Dent 2003;1:7-16.
8. Jansson H, Norderyd O. Evaluation of a periodontal risk assessment model in subjects with severe periodontitis. A 5-year retrospective study. Swed Dent J 2008;32:1-7.
9. Fine DH, Mandel ID. Indicators of periodontal disease activity: an evaluation. J Clin Periodontol 1986;13:533-546.
10. Giannobile WV, Beikler T, Kinney JS, Ramseier CA, Morelli T, Wong DT. Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 2009;50:52-64.
11. Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis--a review. J Clin Periodontol 2000;27:453-465.
12. Edgar WM. Saliva: its secretion, composition and functions. Br Dent J 1992;172:305-312.
13. Gorr SU. Antimicrobial peptides of the oral cavity. Periodontol 2000 2009;51:152-180.
14. Azevedo LF, Pecharki GD, Brancher JA et al. Analysis of the association between lactotransferrin (LTF) gene polymorphism and dental caries. J Appl Oral Sci 2010;18:166-170.
15. Walker TR, Land ML, Kartashov A et al. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007;44:414-422.
16. Sidhu R, Wilson P, Wright A et al. Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel? Aliment Pharmacol Ther 2010;31:1365-1370.
17. Jones J, Loftus EV Jr, Panaccione R et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008;6:1218-1224.
18. Gisbert JP, Bermejo F, Perez-Calle JL et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009;15:1190-1198.
19. Groenink J, Walgreen-Weterings E, Nazmi K et al. Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis. J Clin Periodontol 1999;26:269-275.
20. Fine DH, Furgang D, Beydouin F. Lactoferrin iron levels are reduced in saliva of patients with localized aggressive periodontitis. J Periodontol 2002;73:624-630.
21. Tsai CC, Kao CC, Chen CC. Gingival crevicular fluid lactoferrin levels in adult periodontitis patients. Aust Dent J 1998;43:40-44.
22. Flemmig TF. Periodontitis. Ann Periodontol 1999;4:32-38.
23. Mühleman H, Son S. Gingival sulcus index. A leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-113.
24. Al-Tarawneh SK, Border MB, Dibble CF, Bencharit S. Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS 2011;15:353-361.
25. Kawas SA, Rahim ZH, Ferguson DB. Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. Arch Oral Biol 2012;57:1-9.
26. Suomalainen K, Saxen L, Vilja P, Tenovuo J. Peroxidases, lactoferrin and lysozyme in peripheral blood neutrophils, gingival crevicular fluid and whole saliva of patients with localized juvenile periodontitis. Oral Dis 1996;2:129-134.
27. Jentsch H, Sievert Y, Gocke R. Lactoferrin and other markers from gingival crevicular fluid and saliva before and after periodontal treatment. J Clin Periodontol 2004;3:511-514.
28. Nishida N, Yamamoto Y, Tanaka M et al. Association between involuntary smoking and salivary markers related to periodontitis: a 2-year longitudinal study. J Periodontol 2008;79:2233-2240.
29. Kibayashi M, Tanaka M, Nishida N et al. Longitudinal study of the association between smoking as a periodontitis risk and salivary biomarkers related to periodontitis. J Periodontol 2007;78:859-867.
30. Olson BL, McDonald JL, Gleason MJ et al. Comparisons of various salivary parameters in smokers before and after the use of a nicotine-containing chewing gum. J Dent Res 1985;64:826-830.
31. Dodds MW, Yeh CK, Johnson DA. Salivary alterations in type 2 (non-insulin-dependent) diabetes mellitus and hypertension. Community Dent Oral Epidemiol 2000;28:373-381.
32. Tabak L, Mandel ID, Karlan D, Baurmash H. Alterations in lactoferrin in salivary gland disease. J Dent Res 1978;57:43-47.
33. Jalil RA, Ashley FP, Wilson RF, Wagaiyu EG. Concentrations of thiocyanate, hypothiocyanite, 'free' and 'total' lysozyme, lactoferrin and secretory IgA in resting and stimulated whole saliva of children aged 12-14 years and the relationship with plaque accumulation and gingivitis. J Periodontal Res 1993;28:130-136.
34. Joss A, Adler R, Lang NP. Bleeding on probing. A parameter for monitoring periodontal conditions in clinical practice. J Clin Periodontol 1994;21:402-408.
35. Matuliene G, Pjetursson BE, Salvi GE et al. Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. J Clin Periodontol 2008;35:685-695.
36. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011;474:307-317.
37. Indriolo A, Greco S, Ravelli P, Fagiuoli S. What can we learn about biofilm/host interactions from the study of inflammatory bowel disease. J Clin Periodontol 2011;38:36-43.
38. Bachrach G, Muster Z, Raz I et al. Assessing the levels of immunoglobulins in the saliva of diabetic individuals with periodontitis using checkerboard immunodetection. Oral Dis 2008;14:51-59.
39. Sandholm L, Gronblad E. Salivary immunoglobulins in patients with juvenile periodontitis and their healthy siblings. J Periodontol 1984;55:9-12.
40. Hagewald S, Bernimoulin JP, Kottgen E, Kage A. Salivary IgA subclasses and bacteria-reactive IgA in patients with aggressive periodontitis. J Periodontal Res 2002;37:333-339.
41. Hagewald S, Bernimoulin JP, Kottgen E, Kage A. Total IgA and Porphyromonas gingivalis-reactive IgA in the saliva of patients with generalised early-onset periodontitis. Eur J Oral Sci 2000;108:147-153.